Showing results (61-70 of 226) with videos related to
Sort By:
Pageof 23
The Journal of Biological Chemistry|June 24, 2010
Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptorMicah L Burch, Mandy L Ballinger, Sundy N Y Yang, et al.Personalized Medicine|May 2, 2018
A comparison of Australian and French families affected by sarcoma: perceptions of genetics and incidental findingsVictoria Rasmussen, Laura E Forrest, Muriel Rogasik, et al.British Journal of Cancer|June 26, 2023
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterationsSubotheni Thavaneswaran, Maya Kansara, Frank Lin, et al.Endocrinology|July 9, 2010
PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDLRobel Getachew, Mandy L Ballinger, Micah L Burch, et al.The Journal of Pharmacy and Pharmacology|June 7, 2013
Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cellsPeter J Little, Muhamad Ashraf Rostam, Terrence J Piva, et al.Cancer Research|November 14, 2019
Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter CohortsSeung Jun Shin, Elissa B Dodd-Eaton, Gang Peng, et al.Cancers|May 27, 2026
Risk Factors in Sporadic Early-Onset Colorectal Cancer, Current Evidence and Emerging Insights: A Systematic ReviewMeghana Maddula, Jordan E Cohen, Dulitha Kumarasinghe, et al.Future Oncology (London, England)|September 28, 2023
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissueAntony J Mersiades, Benjamin J Solomon, David M Thomas, et al.BMJ Open|February 10, 2025
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 gliomaKristen McParland, Eng-Siew Koh, Benjamin Kong, et al.Journal of Cellular and Molecular Medicine|September 17, 2009
Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivoMandy L Ballinger, Narin Osman, Kazuhiko Hashimura, et al.Pageof 23